In This Article:
Over the last 7 days, the United States market has remained flat, yet it has shown a robust annual growth of 7.2% and anticipates an earnings increase of 14% per annum in the coming years. In this context, growth companies with high insider ownership can be appealing as they often indicate confidence from those closest to the business while potentially aligning with broader market optimism.
Top 10 Growth Companies With High Insider Ownership In The United States
| Name | Insider Ownership | Earnings Growth |
| Super Micro Computer (NasdaqGS:SMCI) | 14.1% | 34.1% |
| Duolingo (NasdaqGS:DUOL) | 14.3% | 39.5% |
| FTC Solar (NasdaqCM:FTCI) | 32.7% | 61.8% |
| Credo Technology Group Holding (NasdaqGS:CRDO) | 12.2% | 65.1% |
| Niu Technologies (NasdaqGM:NIU) | 36% | 82.8% |
| Astera Labs (NasdaqGS:ALAB) | 15.3% | 61.4% |
| Clene (NasdaqCM:CLNN) | 19.4% | 64% |
| BBB Foods (NYSE:TBBB) | 16.2% | 29.9% |
| Enovix (NasdaqGS:ENVX) | 12.1% | 58.4% |
| Upstart Holdings (NasdaqGS:UPST) | 12.6% | 100.2% |
Let's explore several standout options from the results in the screener.
Astrana Health
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Astrana Health, Inc. is a healthcare management company offering medical care services in the United States, with a market cap of approximately $1.80 billion.
Operations: The company's revenue is primarily derived from three segments: Care Delivery ($136.67 million), Care Partners ($1.95 billion), and Care Enablement ($155.45 million).
Insider Ownership: 11%
Astrana Health demonstrates potential as a growth company with high insider ownership, despite recent challenges. The company's revenue is forecast to grow at 14.2% annually, outpacing the broader US market. However, profit margins have declined from 4.4% to 2.1%. Recent executive changes include appointing Glenn W. Sobotka as Chief Accounting Officer, which could impact financial strategy positively given his extensive experience in senior roles across health companies like Arkos and Carbon Health.
-
Delve into the full analysis future growth report here for a deeper understanding of Astrana Health.
-
Upon reviewing our latest valuation report, Astrana Health's share price might be too pessimistic.
TeraWulf
Simply Wall St Growth Rating: ★★★★★☆
Overview: TeraWulf Inc. operates as a digital asset technology company in the United States, with a market cap of approximately $1.15 billion.
Operations: The company generates revenue primarily from digital currency mining, amounting to $140.05 million.
Insider Ownership: 14.3%
TeraWulf shows promise with a forecasted revenue growth of 40% annually, surpassing the US market's average. While it aims to achieve profitability within three years, its financial position is strained with less than a year of cash runway. Despite recent shareholder dilution, the company completed a $150 million buyback program. Recent earnings reported sales of US$140.05 million, doubling from the previous year, though net losses remain significant at US$72.42 million.